MAP3K7CL 抗体 (C-Term)
Quick Overview for MAP3K7CL 抗体 (C-Term) (ABIN629829)
抗原
See all MAP3K7CL 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- C-Term
-
特异性
- C21 ORF7 antibody was raised against the C terminal Of C21 rf7
-
纯化方法
- Purified
-
免疫原
- C21 ORF7 antibody was raised using the C terminal Of C21 rf7 corresponding to a region with amino acids DSEESMEVFKQHCQIAEEYHEVKKEITLLEQRKKELIAKLDQAEKEKVDA
-
-
-
-
应用备注
-
WB: 1.25 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
说明
-
C21ORF7 Blocking Peptide, (ABIN937547), is also available for use as a blocking control in assays to test for specificity of this C21ORF7 antibody
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of C20 RF7 antibody in PBS
-
浓度
- Lot specific
-
缓冲液
- PBS
-
注意事项
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
储存条件
- 4 °C/-20 °C
-
储存方法
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- MAP3K7CL (MAP3K7 C-Terminal Like (MAP3K7CL))
-
别名
- C21ORF7
-
背景
- C21orf7 plays a critical role in the TGF-beta signaling transduction pathway.
-
分子量
- 27 kDa (MW of target protein)
抗原
-